How It Works AOD9604 is a modified fragment of the Cterminal region of human growth hormone (amino acids 177191) that appears to mimic GHs effects on fat metabolism without significantly affecting IGF1 or overall growth hormone levels
In placebo-controlled adjunctive epilepsy trials in adults receiving topiramate 200 to 1,000 mg/day, hot flashes (1% to 2%), drug-induced body odor (0% to 1%), skin disorder (1% to 2%), hyperhidrosis (1% or less), and erythematous rash (1% or less) were reported with equal or greater frequency than placebo
More Information What is the trek to Choquequirao and why is it so special
Second, preclinical tissue-repair findings do not mean that human wound healing, injury recovery, or disease treatment has been established
2019;70(s1):S145S163
What should I do if I miss a dose